Skip to main content
. 2022 Aug 27;14(8):754–764. doi: 10.4240/wjgs.v14.i8.754

Table 1.

Demographic and clinicopathological characteristics for patients in two cohorts


OG (n = 48)
3DLAG (n = 36)
P value
Age (yr) 60.62 (10.11) 61.19 (9.90) 0.797
Gender (%) 1.000
Male 42 (87.5) 32 (88.9)
Female 6 (12.5) 4 (11.1)
BMI (kg/m2) 21.65 (3.22) 22.26 (2.59) 0.355
ASA (%) 0.384
1 1 (2.1) 0 (0.0)
2 33 (68.8) 29 (80.6)
3 14 (29.2) 7 (19.4)
Previous disease (%) 0.54
Benign 17 (35.4) 16 (44.4)
Malignant 31 (64.6) 20 (55.6)
Primary reconstruction (%) 0.617
Billroth Ⅰ 16 (33.3) 12 (33.3)
Billroth Ⅱ 22 (45.8) 20 (55.6)
Roux-en-Y 4 (8.3) 1 (2.8)
Tube-like Stomach esophagogastrostomy 6 (12.5) 3 (8.3)
Interval time (d) 211.56 (197.35) 237.97 (209.01) 0.556
Site of CRS (%) 0.352
Non-anastomosis 22 (45.8) 12 (33.3)
Anastomosis 26 (54.2) 66.7)

All continuous variables were described by mean ± SD; enumeration data were presented by percentage (%). OGC: Open gastrectomy for carcinoma in the remnant stomach; 3DLAGC: 3D laparoscopic assisted gastrectomy for carcinoma in the remnant stomach; BMI: Body mass index; CRS: Carcinoma in the remnant stomach.